Skip to content
OpenCapital
Get started

Artiva Biotherapeutics, Inc. ARTV Q4 2025 Annual earnings

Reported March 10, 2026 · Before market open

Revenue-Diluted EPS-$0.84Beat by $0.03
EPS estimate-$0.87

Next report

Aug 5, 2026 (in a month)
EPS estimate-$0.64

Financials

Q4 2025

Income statement

See full
Revenue-—
Operating income-$21.9M-20.1%
Net income-$20.8M-29.1%
EPS (diluted)-$0.84—

Balance sheet

See full
Cash & equivalents$27.2M-32.9%
Total debt$10.9M-23.8%
Total equity$110.0M-41.1%
Total assets$130.9M-37.5%

Cash flow

See full
Operating cash flow-$14.7M-0.5%
CapEx$421.0K+558%
Free cash flow-$15.1M-2.9%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$105.3M-57.0%
Enterprise value$89.08M-59.3%

Returns & leverage

See full
Return on equity-56.5%—
Debt / equity0.1×0.0×
Current ratio8.6×-6.8×

Versus estimates

Diluted EPS

Q1 2026-$0.95Miss by $0.07
Q4 2025-$0.84Beat by $0.03
Q3 2025-$0.88Beat by $0.04Q2 2025-$0.87Miss by $0.03Q1 2025-$0.83Miss by $0.15Q4 2024-$0.66Beat by $0.05

Ask the moment Artiva Biotherapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Artiva Biotherapeutics, Inc. report Q4 2025 earnings?
Artiva Biotherapeutics, Inc. (ARTV) reported Q4 2025 earnings on March 10, 2026 before market open.
What were Artiva Biotherapeutics, Inc.'s Q4 2025 revenue and EPS?
Artiva Biotherapeutics, Inc. reported revenue of - and diluted EPS of $-0.84 for Q4 2025.
Did Artiva Biotherapeutics, Inc. beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.87 by $0.03.
How did Artiva Biotherapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 27.3% from $-0.66.
Where can I find Artiva Biotherapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-100131) and the 10-K periodic report (0001193125-26-100135) directly on SEC EDGAR. The filing index links above go to sec.gov.